| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/10/2008 | US20080085325 Dialysis Solution, Formulated And Stored In Two Parts, Comprising Phosphate |
| 04/10/2008 | US20080085295 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 04/10/2008 | US20080085280 Using monoclonal antibody specific to bacterial ectodomain as tool in prevention and treatment of pancreatic, kidney and inflammatory disorders |
| 04/10/2008 | US20080085244 comparing levels with untreated ovariectomized animal determining amount of an estrogen to reduce amyloid peptides in brain of an animal without affecting soluble APP level; administering test compound to an ovariectomized non-human animal; beta.17-estradiol reversed ovx-associated levels; Alzheimer's |
| 04/10/2008 | US20080085242 modified biodegradable branched chitosans effectively complexed with nucleic acids |
| 04/10/2008 | DE102006046959A1 Producing a standardized thrombocyte concentrate comprises separating a thrombocyte-rich fraction (TRF) from pooled donor material, testing and/or standardizing the TRF, and dividing the TRF into standardized units |
| 04/10/2008 | CA2667082A1 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| 04/10/2008 | CA2665392A1 Anticoagulant compounds |
| 04/09/2008 | EP1908781A2 Modulation of immune response and methods based thereon |
| 04/09/2008 | EP1908768A1 Anticoagulant compounds |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908481A1 Agent for reduction of bleeding in cerebrovascular disorder |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908470A1 Peritoneum protecting agent |
| 04/09/2008 | EP1907388A1 Novel heteroaryl fused cyclic amines |
| 04/09/2008 | EP1907363A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 04/09/2008 | EP1906993A2 USE OF FACTOR VIIa OR FACTOR VIIa EQUIVALENTS FOR PREVENTING OR ATTENUATING HAEMORRHAGE GROWTH, AND/OR OEDEMA GENERATION FOLLOWING INTRACEREBRAL HAEMORRHAGE (ICH) IN PATIENTS TREATED WITH ANTIPLATELET THERAPY |
| 04/09/2008 | EP1906975A2 Method for treating sickle cell disease and sickle cell disease sequelae |
| 04/09/2008 | EP1439837B1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1280540B1 Modified factor viii |
| 04/09/2008 | EP0971958B1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160137A Use of CD 25antibody in immunity treatment |
| 04/09/2008 | CN101160130A Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome |
| 04/09/2008 | CN101157710A Method for preparing iron supplementary carboxymethyl Chitosan oligosaccharide ferrous |
| 04/09/2008 | CN101156937A Medicine wine for curing rheumatism, gout and hydrocele disease |
| 04/09/2008 | CN101156896A A fumigant medicine for treating angitis and method for making same |
| 04/09/2008 | CN101156894A Mass control method of apricot red injection |
| 04/09/2008 | CN101156866A Application of pian-nuo-zao-gan in preparing stypticum |
| 04/09/2008 | CN101156863A A medicine composition for treating cardiac and cerebral vascular disease and its medical usage |
| 04/09/2008 | CN101156842A Pharmaceutical preparation containing arginine glutamic acid |
| 04/09/2008 | CN101156690A Sleep-regulating and anti-senile nutrition health products and method for making same |
| 04/09/2008 | CN101156685A Health-care nutritive mush |
| 04/09/2008 | CN101156680A Food composition of nourishing blood anti-senescence and method for producing same |
| 04/09/2008 | CN100379760C Peptides and compounds that bind to receptor |
| 04/09/2008 | CN100379751C Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 04/09/2008 | CN100379722C New compounds |
| 04/09/2008 | CN100379456C Preparation for the prophylaxis of restenosis |
| 04/09/2008 | CN100379430C Sturgeon chondroition capsule and instant granula preparation method therefor |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7354947 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 04/08/2008 | US7354761 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354585 Methods of treating coagulapathic or thrombotic disorders |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/03/2008 | WO2008040002A2 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/03/2008 | WO2008039473A2 Alcohol free formulation of argatroban |
| 04/03/2008 | WO2008039085A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | WO2008038777A1 Therapeutic agent for disseminated intravascular coagulation syndrome |
| 04/03/2008 | WO2008038175A2 Dithiolopyrrolones compounds and their therapeutic applications |
| 04/03/2008 | WO2008037922A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 04/03/2008 | WO2008037365A1 Mixture of iron and copper salts masking metallic taste |
| 04/03/2008 | WO2008021124A3 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 04/03/2008 | WO2007135182A3 Factor ix analogues having prolonged in vivo half life |
| 04/03/2008 | WO2007131973A3 Compositions and methods for modulating the immune system |
| 04/03/2008 | WO2007112052A3 Formulations and methods for vascular permeability-related diseases or conditions |
| 04/03/2008 | US20080081788 reduce the elevated level of free IgE in patient's serum by oral administering peptide biodrug; also can reduce nerve growth factor, myoglobin, Insulin, adenosine deaminase; treating asthma, type 2 diabetes, depression, autoimmune diseases, diabetes, Graves' disease, Addison's disease, Hodgkin's disease |
| 04/03/2008 | US20080081783 Utilizing amino acid sequences linked to polyethylene glycol as agonists; increasing red blood cell production; chronic kidney disease |
| 04/03/2008 | CA2665907A1 Derivatives of 5-thioxylopyranose and use of same for treatment |
| 04/03/2008 | CA2664744A1 Triphenylphosphonium thionitrite nitric oxide donors |
| 04/03/2008 | CA2664406A1 Mixture of iron and copper salts masking metallic taste |
| 04/03/2008 | CA2664290A1 Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905457A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 04/02/2008 | EP1904474A1 New pyridine analogues |
| 04/02/2008 | EP1904074A1 USE OF LACTOBACILLUS FOR INCREASING THE ABSORPTION OF A METAL CHOSEN FROM Fe, Zn, Ca AND IONS THEREOF |
| 04/02/2008 | EP1397153B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 04/02/2008 | EP1274729B1 G protein coupled receptor |
| 04/02/2008 | CN101153303A Method for producing Baihuajimu flavone |
| 04/02/2008 | CN101152562A Medicament combination for regrouping leech essence |
| 04/02/2008 | CN101152560A Segmented intestine target drug administration preparations of blood protein polypeptide and method for preparing the same |
| 04/02/2008 | CN101152455A Medicine for external application for treating hemiparalysis |
| 04/02/2008 | CN101152433A Traditional Chinese medicine for treating chemotherapy leukocytopenia after mammary cancer operation |
| 04/02/2008 | CN101152366A Traditional Chinese medicine for treating gestational edema |
| 04/02/2008 | CN101152359A Health care medicinal liquor and preparation method thereof |
| 04/02/2008 | CN101152298A Traditional Chinese medicine for treating pregnancy general edema |
| 04/02/2008 | CN101152290A Externally used powder preparation stypticum |
| 04/02/2008 | CN101152285A Pharmaceutical composition of snakegourd fruit and whitethorn leaf |
| 04/02/2008 | CN101152246A Pharmaceutical composition for cardiovascular and cerebrovascular diseases and method for preparing the same |
| 04/02/2008 | CN101152243A Traditional Chinese medicine for treating apoplexy and technique of preparing the same |
| 04/02/2008 | CN101152221A Traditional Chinese medicine for treating cerebrovaseular disease |
| 04/02/2008 | CN101152220A Prescription for treating hydropsy of pigling |
| 04/02/2008 | CN101152205A Inosine injection and method of preparing the same |
| 04/02/2008 | CN101152147A Ligustrazine compound emulsion and method for preparing the same |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100377749C Stent grafts with bioactive coatings |
| 04/02/2008 | CN100377742C Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 04/01/2008 | US7353152 Method and apparatus for computer modeling diabetes |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351800 Stabilized albumin preparations |